Invion Ltd has released a press release.
Appendix 4C - December quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Appendix 4C - September 2018 quarter
- New Photosoft formulation increased effect in ovarian cancer
- Spin out of respiratory assets for development in China
- Appendix 4E Annual Report and Full Year Statutory Accounts
- Appendix 4C - June 2018 quarter
Later from Invion
- General Meeting - Results of Meeting
- Invion completes spin-out of respiratory assets
- Response to ASX Appendix 4C Query
- Appendix 4D and Financial Report for Half Year to 31 Dec 18
- Quarterly Update
Follow Invion into a list and get an email when it puts out news.
Follow Invion